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Plasma and myocardial tissue concentrations or metaprohel wore
studied in ischemic and noniuhemic areas of 22 pigs after 90 in =
19)and 16 (a = 3) min of let anterior desceod ing coronary artery
occlusion . Group A In = 6) received simultaneous intravenous
metoprobl 10
.2 mg'kg body weight) and tritium-labeled
All .
tnetoprolol (0 .2 al retrogradely into the snronary rein. In
group B fn = 51, rneioprolot and sH-metoprdot were administered
in the same way, but a) half The volume to study the influence of
derived coronary venous pressure on the myneardlal concentra-
tion of drug . fn group C (n = 3), nwtoprolol was given retro-
gradely and saline solution
was infused into the teh anterior
descending artery before induced death to wash out metoprolol
from the coronary veins
. To rule out a possible influence of the
development of mynnrdfal necrosis em drug distribution, mety-
pratvl was rcrolnfnsed after I
min of arterial occlusion in three
pigs (group III
.
In group E In = 51, meroprotol (0 .2 mgfkg) wee
infused unterngradely Into the left anterior
descending artery
.
Peak plasnacymrnlration was significantly higher afkr intra-
venous infusion of metoprnlol (1,1118 i SO neaolllitml than after
coroari venous infusion (417 ± 155 nmolliter ; p < 0
.11111 1 . In
getups A and B. the nonischemle myocardial conceedralion of
metoprdnl was 25010 300 pea0Ug, whether the drug was infused
intravenously or into the coronary vein. Coronary venous reko-
infusion, however, resulted in a substantial accumulation of
metoprolnl in the isehemir myocardium- In group A pigs, nohen-
docardial myocardial concentration was 16,01111 ± 7,774, mid-
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39,590 x 18,043 and subepieardfal 57,143 ±
29,0391 pmal'g Imean v SE1 . The iwhemic myocardial cunreatra-
lion in pigs from group B was somewhat less pronounced,
probably secondary to a lower coronary venous pressure T15 ±
3 mm Hg) with the lower volume of infusion 16 .1 ± 0.3 nd) in
group B compared with 32 ± 5 mm Hg with a 14 ± I ml infusion
in group A. Coronary artery anterograde administration resulted
in myocardial ischemic and nodschemic zone drug concentrations
similar to those observed after retroinfusion into the coronary
vein. With both modes of administration, there was a Iransmyo-
cordial gradient from a somewhat lower drug concentration in the
subendocardinm, toward an Increasing level in the mid.
myocardium, in The highest concentration in the suhtpkardal
nosy of the ischemit to locardiuno,
Coronary venous retrotnfasion resulted in pronounced drug
rnalation in the ischema•
myocardium.
The derived coronary
venous pressure during infusion influenced
the concentration of
drug . The ischemit myocardial levels and distribution pattern
were similar to those wen with coronary artery anlerograde
infusion . The high 6ssve levels of drug were not affected by saline
solution fill These findings suggest
that coronary venous ret-
rninfusion may deliver drug, to a wicrovascular level of schnook
myocardium, with a distribution
similar m that achieved after
direst arterial infusion .
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PHARMACOKINETICSOFCORONARY VENOUS RETROPERFUSION
After experiments with retroperfusion of arterial blood into
the coronary veins of freshly extirpated cat hearts . Pratt (II
in 1893 concluded that "the nutrition of the mamatalian heart
is not completely dependent on the coronary arteries." In
1948 . Beck et al . (2) introduced the concept of coronary
sinus perfusion into clinical medicine with the Beck 11
surgical procedure . whereby blood was shunted from the
aorta to the coronary sinus. Despite short-term improvement
of cardiac function in patients with ischemic heart disease .
this technique was abandoned because of late complications
mainly secondary to myocardial edema and hemorrhage .
Interest in coronary venous interventions in 1976 was re-
newed with the introduction of synchronized coronary
venous retroperfusion by Meerbaum et aL (3). Originally,
coronary venous interventions were intended for the retro-
grade delivery of arterial blood for temporary support of
acutely ischemic myocardium (4,5) . However, it was soon
evident that the coronary veins also provided a route fur the
administration of pharmacologic agents (6,7) . Thus, coro-
nary venous retroinfusion refers to a technique for the
coronary venous delivery of pharmacologic agents to the
myocardium. This application may be used together with
retroperfusion or independently (4,5) .
Recent experimental evidence (6,8 .9) demonstrates ben-
efits from the retroinfhsion of vzrious pharvtaeo!cgic agents
such as streptokinase, procainamide, diltiazem and oxygen
free radical scavengers . Consequently, coronary venous
retroinfusion may have future important clinical potential .
There is, however, only scattered and limited information on
pharmacokinetics after retroinfusion . In a recent pilot inves-
tigation we (10) found that coronary venous retroinfusion of
the beta-adrenergic blocking agent metoprolol resulted in a
pronounced drug accumulation in the ischemic myocardium
of pigs after coronary artery ligation and that this drug would
be suitable as a tracer in a more extensive pharmacokinetic
study of coronary venous retroinfusion of drugs .
The aim of the present investigation was to compare
systemic intravenous and retrograde coronary venous ad-
ministration of drugs in terms of the distribution in plasma
and ischernic and nonischemic myocardium . Furthermore,
we wanted to test the hypothesis that delivery of drug into
the coronary venous system may result in an accumulation
of drug in the ischemic myocardium similar to that achieved
by anterograde infusion into the coronary arteries .
Methods
Animal preparation . Twenty-two male or female farm
pigs weighing 27 to 45 kg (mean ± SE 34 2 1) Acre included.
The pigs were premeditated with intramuscular injections of
ketamine hydrochloride (20 mg/kg body weight) and atropine
(0 .1 mg/kg) . Anesthesia was induced by an intravenous
injection of sodium pentobarbital (20 to 30 mg/kg) and
maintained by a continuous infusion of this agent (2 to
6 mg/kg per h). A tracheotomy was performed and the pigs
were ventilated mechanically by a Harvard respirator . Res-
JACC vol. iv . No. 2
Augur[ 1991:603-12
I
S
~
At vial
11
1
~~C I
ACA
C ~'
IsehEmiC
Zone
E_3
I CCVHusurs
Figure 1 . Schematic illustration of the experimental porcine prepa-
ration, demonstrating the position of the snares around the left
anterior descending (LAD) coronary artery and the position of the
coronary sinus catheter . Stippled ma outlines the ischemic zone .
Snare I was used for partial left anterior descending artery ocelu-
siaa ; the Complete occlusion was applied by snare 2 . This protocol
was used in groups A, B, C and E . In pigs in group C, complete left
anterior descending artery occlusion was directly applied at the site
of snare 2 . Pigs in group C and E also had an la gauge Angiocath
insured into left anterior descending artery at the site of snare 2 .
The lower 111ma arlon shows the apical, mid-left ventricular and
basal slabs for study of ischemic and nonischemic areas . Ai vein =
anterior cardiac vein ; GCV = great cardiac vein ; LCX = left
circumflex coronary artery; RCA = right coronary artery .
piratory rate and tidal volume were adjusted to keep the pH
and partial pressure of carbon dioxide (Peo2) within the
normal range . Body temperature was kept between 37 .5° and
38°C .
Two 4F catheters introduced through the femoral veins
were positioned in the inferior vena cava for the administra-
tion of drugs and fluids and withdrawal of blood specimens
(Fig . I). A 7F catheter positioned in the aortic arch through
the left carotid artery was used to measure aortic blood
pressure by means of a Statham P23Db transducer
. An 8F
IACC Vnl . I5, N,, 2
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PH4eMACITKO OF CORONARY VENOUSRETROPERFUSION
Table 1. Pertinent Data From the Experimental procedure in the IF- Groups of Pig .,
LAD = left anterior descending coronary artery,
M!KRO-TIP catheter transducer (Millar Instruments) in-
serted through the right carotid artery was positioned in the
left ventricle to record pressure . The first derivative of left
ventricular pressure (dlaldt) was obtained by electronic der-
ivation . In pigs that received coronary venous retroinfusion .
an 8F catheter was inserted through the left external jugular
vein and advanced into the coronary sinus orifice,
Access to the heart was achieved by a left thoracotomy in
the fifth intercostal space and the pericardium was opened .
In all pigs except those belonging to group D (sec later), two
silk ligatures were passed around the left anterior descending
coronary artery . One ligature was placed approximately
I em below the first major diagonal haunch and The second
approximately 1 .5 em more distally . Pigs in group I) received
only the proximal ligature
. All pigs except those in group r,
(see later) had a 4F double lumen balloon catheter inserted
through the previously positioned coronary sinus inroducer .
The balloon of the double lumen catheter was positioned in
the anterior interventricular vein just above the site of the
most proximal left anterior descending artery snare . The
center lumen of the catheter was used for the infusion of
metoprolol and the ether for balloon inflation
to occlude the
cardiac vein during drug delivery. A 22 gauge intravenous
catheter (Angioeath) was introduced into a branch of the
anterior interventricolar vein distal to the site of occlusion
for pressure monitoring (Fig . 1) . All pigs received heparin
(3,0001Ulkg intravenously) after instrumentation . Lead II of
the electrocardiogram (EC(i) and all pressures were contin-
uously monitored on an Electronics far Medicine physio-
logic recorder.
Experimental procedure (Table
1)
.
After instrumentation
and before left anterior descending artery occlusion
. control
hemodynamic recordings were obtained in all pigs . The pigs
were assigned to one of five groups: group A T n = 6) . group
B (n = 5), group C In = 3) . group D (n = 3) and group E
(n = 5)
. The most important differences among these groups
are summarized in Table I
. In pigs belonging to groups A .
B, C and E, the distal silk suture was tied around the left
ii ETAL .
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ahterior descending artery and a 20 gouge hypodermic
needle . This needle was immediately removed, leaving the
vessel partly occluded during 30 min, after which the artery
was completely ligated at the proximal site. This sequential
ligation procedure was done to minimize the risk of ventric-
ular fibrillation frequently observed after acute one-stage
coronary artery ligation in pigs ( I I) . After 30 min of com-
plete ischernia, pigs in groups A and B received metoprolol
simultaneously infused into the coronary vein (0.2 mg/kg of
tritium-labeled ['111-metoprolol) and intravenously
10.2 mglkg of unlabeled melnprnlnl) .
Irrrrordiarel y before rile onset ofvelroirrJuaion, the balloon
on the catheter in the amerior intcrventricular vein was
idlfatcd Lo prevent drug regurgitation . The balloon was kcpl
inflated during the 5 min period of infusion and for an
additional 2 min after completion of the infusion . By visual
inspectioni it was ascertained that the inflated balloon oc-
cluded the coronary vein. The only difference between
groups A and B was that meroprolol was given in a concen-
tration of 0.5 mg/ml in group A and I mg/ml in group B .
Accordingly . the infused volume was 14 ± I ml (mean t SE)
in group A and 4.1
r
0 .3 ml in group B. The pigs in groups
A and B were killed 60 min after the start of metoprolo)
infusion,
Pigs in group C were similar to those in groups A and B,
but received only unlabel
l
ed n ,:t .,prolol in the coronary vein,
In these pigs, saline solution (1U ml) was injected during
I min into an 18 guu,te catheter (Angiocath) inserted in the
left anterior descending artery at the time and site of
proximal occlusion . Than, the proximal coronary artery
snare was tied around this catheter .
in omrrp D, the left anterior descending artery was
occluded at the proximal site without prior distal partial
occlusion and unlabeled metoprolo[ was infused into the
coronary vein I min after occlusion in a manner similar to
that previously described . These pigs were killed 15 min
after metoprolol infusion .
In ninny E, the pigs were handled as in groups A and B,
Group
Drug
She at
Into ..
o ,e
Imglkgl
man
Con nntration
tmf/mll Rcmnrka
A In - 6)
BIn=s)
C In = 3)
I
HinNnprotol
Ti
'Wmelnpmkrl
Meloprn6l
Mernprolol
Coronary 'nn
fart) ..
cororarn
Right a n
Comnaryutin
0.2
0.5
Iurmiun :Jlcr 30 min or-nsplclc LAD occlusion,
,educed
drch 60 min later
As i n atom A
As in grasp A . bun vii LAD hush iI0 or of saline
D In = 3) Mctnpmlnl Coronary uvn b .'- 0 s
sulutiarl hum the sir, of ucclusiun before
induced death
Infusion after I min d conrpxle LAD occlusioni
E in - 5) Memprolol LAD o 2 n S
induced Jcaih 15 mie later
lnfucioa after 30 our, of complete LAD acdusiov
insuued death 60 To. two,
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with the except inn that infusion of unlabeled me toprolol was
made into the left anterior descending artery through a
catheter introduced as in group C .
To outline ischemic and nonischemic myocardium, 20 ml
of 10% manastral blue dye was injected into the left atrium at
the end of the ahservatinn period in all pigs, after which the
animals were killed by injection of potassium chloride
.
Recordings and specimens. Hemodynitmie recordings
were made before coronary artery occlusion (cvntrol), be-
fore (01 and at 5 . 15, 30 and 60 min after the start of
mcloprolol infusion. Blood for the analysis of plasma mete-
prolol concentrations was obtained at 5 . 10 . 15 . 20. 10, 45
and 60 min after the start of the infusion. Afar extirpation,
the heart was cut into apical, mid •v enlricularand basal slabs
(Fig . 1) . Ischemic myocardial tissue was derived from each
of these says and nonischemic myocardium was taken from
the mid-ventricular slab . Myocardial tissue from each site
was separated into subendocardial, mid-myocardial and
suhepicardia) pnrtinns
. Plasma and tissue specimens were
kept at -20'C until analyzed .
Analysis of meloprolol, °H•m etoprolol and radioactive
metabolites . The concentrations of metoprolol in tissue he-
mogenates and in plasma originating from the intravenous
dose were calculated from the differences between the
metoprolol concentrations determined by gas chromatogra-
phy mass spectrometry (12.13) and the concentration of
3 H-metoprolol in the same samples . The 'H-metoprolol
concentration was determined by liquid scintillation count-
ing after separation from its metabolites by column liquid
chromatography (14) . Eluted fractions with a retention time
corresponding to the ultraviolet signal of the internal star,-
dard of cold metoprolol werr collected in scintillation liquid
(Ready Safe . Beckman Instruments) and the radioactivity
was measured with a Beckman 3800 liquid scintillation
counter, A validation of the metoprolol assay has been
performed; in the presem set of experiments, considering the
sample size, metoprolol levels >10 pmollg could be deter-
mined with a relative SID of <107o (12 .13), The assay of
"H-metoprolol was tested under the conditions of the present
study : 'H-metoprolol could he quantified with an SD of2 .8%
to 3.8% (n = 10) in a concentration range of 15 to 4[X1 emollg .
Statistics . Statistical methods included analysis of vari-
ance IANOVAI with either one grouping factor and one or
two repeated measures factors . Signiticanl ANOVA effects
(p < 0 .05) were nssessed by Tukey's pairwise multiple
comparison procedure I I5,16)- Within-subject comparisons
were amd-cod with Friedman's analysis of variance using a
ranking procedure (17)
.
Significant results from the Fried-
man let were evaluated by the nonparametric analog of
Tukey's multiple comparison procedure. Between-subject
comparisons were conducted for each level of a repeated
measures factor using a ranking procedure (l7) . Significant
results were determined by the nodpafametric analog of
Tukey's multiple comparison procedure . All data are pre-
sented ac mean values ± SE . A p level < 0 .05 was consid-
ered statistically significant .
JACC star la. Na . 2
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Results
Hemndvnamies ITabtes 2 and 31
. There were no differ-
encei among groups A to E with respect to hemodynamic
variables at control study (before left anterior descending
artery occlusion) or directly before. drug infusion. The infu-
sion of metoprolol did not significanlly influence heart rate,
systemic blood pressure or left ventricular pressure ; how-
ever, metoprolol infusion resulted in a reduction in left
ventricular dP/dt 5 and 15 min after the start of the injection
(Table 21. In group A, occlusion of the coronary vein and
coronary venous retroinfusion caused a significant increase
in mean coronary venous pressure peaking at the end of the
infusion (Table 3) . The pressure increase in group B pigs
receiving the low volume infusion was less pronounced (p =
NSt. At theend efinjection, peakcaronary venous pressure
was 43 a 5 mm Hg in group A, 30 a 6 mm Hg in group B,
47 ± 2 mm Hg in group C and 59 a 5 mm Hg in group D . The
highest peak coronary venous pressure was 66 mm Hg in one
pig in group D .
Plasma concentration (Fig . 2). Plasma metoprolol con-
centrations after intravenous and coronary venous retroin-
fusion in group A are presented in Figure 2 . The results
obtained in the other groups were similar and are therefore
not reported . Mean peak plasma concentration obtained
from intravenous infusion was 1 .188 t
503 nmollliter (unla-
beled metoprolol) compared with 417 ± 155 nmollliter
('H-
metoprolol) with coronary venous reiroinfusion (p < 0 .001).
Plasma levels of the retroinfused 'H-metoprolol remained
significantly lower throughout the 60 min observation period
(p < 0 .051
.
Myocardial concentration (FIg . 3 and 41. Average isch-
anic and nouischemic myocardial tissue drug concentrations
in the subendocardial, mid-myocardial and subepicardial
zones after isnrntrennat injection (unlabeled metoprolol) and
coronary venous retroinfusion (3 H-memprololl in group A
are shown in Figure 3 . Whether given intraYenously or
retrogradely. aonischemic myocardial tissue roocenltajions
were approximately 26) pmollg . Ischemic zone concentra-
tion after coronary venous retroinfusion was substantially
higher, with values of 16.8131 a• 7,774 pmot/g in the suhen-
docardium, 39.59D a 18,043 pmollg in the mid-myocardium
and 57.143 ± 29,03D pmvt/g in the subepicardium, The
difi'erence between nonschcmie and ischemic myocardial
tissue concentrations was statistically significant (p s- 0.05)
as was the tmnsmyocardial gradient, with lowest levels in
the subendacardium and highest levels in the subepicardium
(p < 0 .05). There was very little unlabeled metoprolol
(administered intravenously) in the ischemic and even less in
die nonischemic myocariiuni . Because the concentration
was within the error of the method of analysis (separating
unlabeled from 3H-metoprolol), it could not be defined in
detail . There was a trend toward higher myocardial meto-
prolol concentrations in myocardial slabs from the apical
toward the basal parts of the left ventricle, reaching statis-
IACC Vol . 18 . N,, A
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Table 2 . Hemodynamic Vadahles Before Irfr
AMeriar Descending Coronary Array 0cclasion and at Various Times After
Meloprolol Infusion
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Timr AO,, 11rto,mlol Iminl
'p < 0.077 versos 0 In after meloprolol, Dara are mean values
i
SE for the eiferenl groups, dP di = Or,[ derlvarise n1611-11111 tar ILV) pressure .
tical significance Ip a 0PSI for the subendocardial and
nlid-myocardial zones (Fig . 4) .
EHed of the vanes modes of administration on ischemic
myocardial meloprolol concentration (Fig- 5 and 6 . Table I) .
Wilh use of group A as a standard . there was a trend toward
lower myocardial lissue concentrations after the low, volume
infusion (group B) Wig . 5)
. The coronary artery saline
solution flush befine induced death (group CI did not have
any important influence on the myocardial tissue concentra-
lions. Relroinfusioa of drug I min after complete occlusion
of the left anterior descending coronary artery (group
DI
tended to give a somewhat higher myocardial concentration
than when the drug was given 20 min after occlusion .
Anterograde administration of drug through the left anterior
descending artery (group EI and coronary venous retroinfu-
sion (group A) resulted in comparable myocardial tissue
concentrations. Individual myocardial concentrations did,
however, stow a considerable individual variability IToble
4) . The ischemic myocardial concentration of drug was
related to the mean coronary venous pressure at the end of
infusion
. The correlation for the subendocardial mid-
myocardial and suhepicardial areas was 08851, 0 .8143 and
11 .11160. respectively Ip < 0 .04). The relation is presented in
Figure 6 derived from all 14 pigs in groups A • H and C that
underwent the same coronary artery occlusion protocol .
Discussion
Previous studio . To date. only limited information is
available on myocardial tissue drug concentration after
coronary venous retroinfusion . Karagueuzian et al . (8) stud-
ied the efficacy of retrograde delivery of procainamide for
the management of ventricular tachycardia in dogs with
permanent coronary occlusions . Although not reported in
detail, myocardial procainamide concentration was 9 to 100
times higher in the ischemic left ventricular wall after
retroinfusion than after intravenous administration . In a pilot
study 1101 . we recently demonstrated that coronary venous
retroinfusion of metoprolol resulted in substantial accumu-
lation in ischemic myocardium, with average myocardial
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Table 3
. Mean Coronary Venous Pressure lin mm Hg) Before and
at Various limes After Metoprolol 'nlusion
'P <. 0 .001 versos nor, 00
cvreentfations much higher in ischemic compared with
nonisehemic myocardium. Accordingly, the present study
provides the first extensive pharmacokinetic data supporting
the concept that coronary venous retroinfusion may deliver
pharmacologic agents to ischemic myocardium in a highly
specific way . much more effective than systemic intravenous
Figure 2 . Plasmamelupretol(mc valuc'SE)afteradmiorntralion
of 0 .2 mVkg administered intravenously (dosed circles . unlabeled
metoprolol) and retrogradely (open circles, 7
11-metoprololl into the
coronary vein . Data are derived from group A pigs .
.
.' '	
°	°
30
45
60
Figure 3. Myocardial tissue metoprolol (mean value
-
SCI after
administration of 0 .2 m)kg intravenously (iv .) (unlabeled meto-
prolol) and retrogrdely Iretro .l into the coronary vein tH-
memprnlop of pigs,
administration . The technique with tritium-labeled (3 H) and
unlabeled metoprolol permitted the pigs to be used as their
own controls . ruling out uncertainties introduced by the use
Figure 4. My-dal metoprolol in different ischemic areas from
apex toward the base of the left ventricle (LV) after administration
of 0.2 mg/kg . A. Data derived from group A pigs (coronary venous
retroinfusion)
. B
. Data derived from group E pigs (infusion antero-
gradely in left anterior descending coronary artery) .
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Tablr S. .Myocurdial ConcenIra I son nC Mclunrolul I in pnlnlig Ii94 ill After Coronary
Venous Rcirointusion
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difiereni animals for intravenous versus nowearu' venou, dcercc of lipid solubility will penetrate better into isehemic
administration. myocardium dean will drugs without it (19,19). Metoprolol
Metoprolol myocardial comeentrallons : mechanisms of de- has a retmlvely high level of lipid solubility and accordingly
liter) . In the presence of ischcmia, 4 drug with a large has favorable pharmacoktnebe properties for intravenous
10310100
.r5ube.t. ,Ou1
rl Mi49nyuardOi
~ Sutrpra .Jid
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administration . Nevertheless. intravenous metoprolol pene-
trated the ischemic zone poorly. Retruinfusion of labeled
metoprolol demonstrated a high accumulation of the drug in
the ischemic myocardium. In nonischemic areas, the amount
of labeled drug was similar to the concentration achieved by
intravenous infusion of unlabeled drug . Presumably, the
labeled drug reached nonischemic myocardium by way of
the systemic circulation after drug admixture resulting from
veno-venous shunts and thebesian vein drainage . The accu-
mulation of labeled metoprolol in ischemic myocardium is
the probable reason for the lower plasma concentration after
coronary venous administration
.
Several mechanisms may contribute to the specific drug
delivery to the ischemic zones and the low concentrations in
the nonischemic areas. While being administered into the
coronary vein, the drug would obviously be distributed
primarily within the anatomic region drained by the vein of
rctroinfusion. The drug will have easier access to areas in
which capillary perfusion pressure is low, Finally, without
any anlerograde blood flow through the ischemic area . the
drug may accumulate at a microvascular level without
subsequent washout .
Hemudynamic effects, 1n Ine present study. there were
only minor hernodynamic effects despite the very high
metoprolol concentration in the ischemic myocardium .
However, this area of the heart is nonfunctioning and drug
accumulation in the nonischemic normally functioning myo
cardium was not particularly high, thereby limiting a possi .
ble negative inotropic effect. It is recognized that in the
experimental model used, pigs anesthetized with ketamine
followed by pentobarbital there are only minor effects on
heart rate after treatment with a beta-adrenergic blacker.
This has been documented not only for metoprolol 1101
. but
also for propmnolol (20). Adequate beta-blockade was ver-
ified in these studies by plasma concentration measurements
and isoproterenol infusion, respectively . Therefore- further
testing in animal models better designed for a thorough study
of hemodynamic consequences is necessary .
40
50
Coronary venous relroperfusiun versus anlerograde corn
nary artery infusion. The comparison between coronary
venous retroinfusion (group AI and anlerograde coronary
artery administration (group EI of drug revealed that the
accumulation of drug in ischemic myocardium was of a
similar magnitude and distribution . Comparisons between
anlerograde and retrograde delivery of drugs to the myo-
cardium have not previously been presented . Thus, this
observation represents new and potentially important infor-
mation . Both modes of administration resulted in a transmy-
ocardial gradient with lower concentrations in the suben-
docardial than in the subepicardial zones . It was also of
interest that drug distribution was similar in the different
myocardial slabs from apex toward the base
.
Transmyocardial gradient of metoprolol distribution .
There may he seven[ causes of a trallsmyocardial gradient .
One possibility is trapping of concentrated drug in subepi-
cardial veins . However, such a mechanism is not likely
considering the results in pigs in which an anlerograde saline
solution flush was performed before death was induced .
These pigs (group
CI
had myocardial concentrations similar
to those in pigs that did not receive a saline solution flush .
The result in this group indicates that drug infused through
the coronary veins distributes into the interstitial tissue fluid
rather than in the veins . venules and capillaries .
Evolution of myocardial injury after coronary artery
ligation propagates as a wave front from subendocardial
toward suhepicardial regions . In pigs, 30 min of partial and
30 min of complete coronary artery occlusion are sufficient
to cause severe myocardial damage (21-23) . It may be
assumed that this injury would be most pronounced in the
subendocardial layers and that a no refluw phenomenon may
result in redistribution toward the less injured subepicardial
myocardium
. However, relroinfusion I min after left ante-
rior descending artery occlusion (group DI resulted in myo-
cardial concentration gradients similar to those recorded
after 60 min of occlusion . For procainamide, cell viability is
essential for drug binding because much lower drug levels
IACC V
.J
. 15 . No . 2
Auyml Ov,I.11-12
Figure 6 . Relation bvtwevn the woo,, coronary
veaqus pressure (x axis Iran NO at the end of
coronary venous retroiulusion of 0 .2 mglkg of
metoprolol and the mid-myocardial ischemic tissue
concentration of metoprolol ly axis) in the 14 pigs in
groups A. B and C .
IACC vol . 18. No . 2
A .
. .
19'li :(A3-12
are found in necrotic compal ad with normal or ischemic but
nonneerotic myocardium (24) .
However, the similarity in
metoprolol distribution after I and 90 min of ischemia
suggests that variable cell binding does ml explain the
present results . One obviots reason is that the transmyocar-
dial gradient results from the venous and capillary anatomic
distribution, explaining the similarity in results with antero-
grade and reirograde administration . Another possible ex-
planation is that intrammwl pressure propagation from the
left ventricular cavity makes the suhendncardial myocar-
dium more difficult to penetrate . The relation between mean
coronary venous pressure and myocardial concentration of
drug gives some support to
this laser exptanmion A third
possibility may be Inure rapid drainage of metoprolol from
the subendocardium into the blood of the ventricular cavity
than from the mid -myocardial and snbepieardial zones
.
Role of emonury venous pressure. To promote local ab-
sorption of drug, in the ischemic myocardium . the drug was
prevented from regurgitating by inflating a balloon at the lip
of a coronary venous catheter . It is mandatory to monitor
coronary venous pressure continuously during the infusion
1251 As a general guideline- the peak pressure should never
be >60 mm Hg or the mean pressure >40 mm Hg . In the
present series, one pig had a peak pressure of 66 mm Hg for
a short period of time and four pigs had a mean coronary
venous pressure >40 mm Hg
. There were no signs of
coronary venous damage in any of these animals
: however .
the duration of the infusion was short . The importance of
coronary venous pressure to the efficacy of coronary venous
retroinfusion is demonstrated by the correlation between the
derived myocardial concentration and the mean coronary
venous pressure at the end of infusion
Role of verso-venous shunting . Although coronary venous
retroinfusion of metoprolol in most cases resulted in a high
ischemic myocardial cnnccntralinn . there was great individ-
ual variability . In fact
. some pigs had lower concentrations
in ischemie than in nonischemie myocardium (Table
4)-
The
probable explanation is the effect of verso-venous shunts
directing fractions of the retroinfusale directly into the
cardiac chambers or the veins of the nornsahemlc area 1261 .
The anatomy of vac-venous shunts shows great individual
variability (27 .28) . In the presence of veno-venaus shunting.
coronary venous pressure would be expected to increase
less than in situations where such shunts are scarce or
absent. The pig in group A wi,h the lowest ischemic myn-
cardial drug concentrations also had the lowest mean core
nary venous pressure and the pig in croup B with the highest
drug concentration also had the highest coronary venous
pressure . There must . howeverl be other reasons for this
great individual variability in myocardial concentration be-
cause significant variability was also seen after anterograde
administration .
Study limitations. In this study . formal statistical com-
parisons of intravenous and coronary venous drug retroin-
fusion were made only on the basis of results with labeled
and unlabeled metoprolol between pigs receiving retroin-
RVDEN ET AL.
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fused drug in "high" and "low" volumes and between
anterograde and retrograde drug administration . The number
of pigs used to study the importance of duration of coronary
occlusion and the influence of flushing on myocardial con-
centrations was small. These groups were added only to
IIIU81ratC two possible mechanisms of importance when
discussing the pharmakokinettcs of coronary venous real
I- of drugs . Nevertheless, the similarity between the
results obtained in groups C and D and those in groups A
. B
and E suggests that the conclusions drawn from this study
are juslilied .
Conclusions. Coronary venous retroinfusion results in
pronounced and specific drug accumulation in ischemic
myocardium with drug tissue concentrations similar to those
obtained with anterugrade coronary artery infusion . The
high drug concentrations with retroinfusion do not appear to
be the result of coronary venous trapping of drug . Drug
distribution in ischemic tissue is similar to that achieved by
anterograde administration. Retroinfosion does not cause
any untoward accumulation of drug in nonischemic tissue ;
the retroinfused drug is evenly distributed in the ischemic
area. but with a transmyocardial gradient .
In clinical practice, coronary venous retroinfusion may
allow deliverv of drugs into the ischemic myocardium when
it is not possible to reach this area by anterograde adminis-
tration . It may also permit delivery of very high myocardial
concentrations of drugs, thereby improving the efficacy or
changing the characteristics of cardioective drugs
. Another
possible advantage may be the potential for administration of
very expensive or rare drugs in small but still effective
amounts by the coronary venous romte, giving coronary
venous retroperfusion an economical perspective .
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